Compositions and Methods to Regulate Renalase in the Treatment of Diseases and Disorders
US-2017226228-A1 · Aug 10, 2017 · US
US12234500B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12234500-B2 |
| Application number | US-201816958945-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 27, 2018 |
| Priority date | Dec 29, 2017 |
| Publication date | Feb 25, 2025 |
| Grant date | Feb 25, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to compositions and methods for binding and detecting or measuring renalase. In one embodiment, the renalase binding molecule measures renalase amount or activity. Thus, in diseases and conditions where a measurement of renalase is beneficial, such renalase binding molecules may act as diagnostics.
Opening claim text (preview).
What is claimed is: 1. A reference standard consisting of RPC1 (SEQ ID NO:226), RPC2 (SEQ ID NO:227), or RPC3 (SEQ ID NO: 228).
acting on NADH or NADPH (1.6), e.g. those with a heme protein as acceptor (1.6.2) (general), Cytochrome-b5 reductase (1.6.2.2) or NADPH-cytochrome P450 reductase (1.6.2.4) · CPC title
Single chain antibody (scFv) · CPC title
Complementarity determining region [CDR] · CPC title
Glycosylation, sialylation, or fucosylation · CPC title
multispecific · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.